OBJECTIVE: To characterize the effect(s) of gender, age (glycemic status) and obese state, on hepatic biotransformation activities, expression of cytochrome P450 (CYP450) mRNAs and glutathione transferase activity in the obaob mouse. DESIGN: Male and female, obaob or oba mice were killed at 3 ± 4 months or 7 ± 8 months of age. Hepatic microsomes, cytosol and RNA were prepared from each animal. ANIMALS: Male and female obaob and oba mice, 3 ± 4 or 7 ± 8 months of age. MEASUREMENTS: CYP450 form-speci®c activities of CYP1A1a1A2, CYP3A and CYP2B were estimated by determining the 0-dealkylation of alkoxyresoru®n substrates (ethoxy-EROD, benzoxy-BROD and pentoxy-resoru®n, PROD, respectively). CYP2E1-dependent, 4-nitrophenol hydroxylase (PNP-OH) and CYP3A-dependent erythromycin N-demethylase (ERY-DM) were also measured in hepatic microsomes. CYP1A2, CYP2E1 and CYP3A protein in microsomal fractions was determined by ELISA. Glutathione transferase activity (GST) was determined in hepatic cytosol and CYP1A2 and CYP2E1 mRNA was estimated by Northern blot analysis. RESULTS: Female mice, regardless of glycemic status, showed an obesity enhanced level of CYP2E1-dependent PNP-OH activity and CYP2EI protein as shown by ELISA. These increases were observed to be independent of the diabetic state, since 7 ± 8 month-old mice had blood glucose levels identical to lean mice. The mRNA level of CYP2E1 in female mice also exhibited age-and obesity-in¯uenced decreases in expression. No signi®cant differences in CYP2E1 activity or expression were observed in male mice. CYP3A-dependent ERY-DM activity was signi®cantly higher in young males, regardless of phenotype. CYP3A and CYP2B activities did not differ among any animals; however, CYP1A activity, while depressed in obese animals of both genders, was signi®cantly different in old animals. Glutathione Stransferase activity was lower in obese male mice, whereas no difference was observed between lean and obese females CONCLUSION: This study supports earlier observations in man and rats that the obese state produces alterations in the expression of important oxidation and conjugation pathways. In addition, this report more thoroughly examines the role of gender and glycemic status on biotransformation activities in the obaob mouse as demonstrated by increased CYP2E1 protein and CYP2E1-dependent activity in obese females, decreased CYP1A2 protein and CYP1A2-dependent activity in obese animals, and obesity had no effect of glutathione transferase in female mice, in contrast with the previously reported obesity-dependent decrease of this activity in male mice.
Introduction
Obesity is one of the most common af¯ictions in the United States. The Second National Health and Nutrition Survey (NHANES II) characterized 25 ± 30% of the adult population as overweight. Obese individuals have higher relative mortality than lean or normal weight persons and this increased risk is related to increased incidence of hypertension, atherosclerosis, diabetes and a variety of cancers. 1 Obesity has been demonstrated to alter the disposition of several drugs in humans. Changes in hepatic clearance of compounds undergoing Phase I and Phase II metabolism is well described. 2 In addition, numerous genetic and nutritional obese rodent models have demonstrated alterations in hepatic cytochrome P450 (CYP450) and conjugation pathways. These studies have shown increased susceptibility or increased protection to xenobiotic induced target organ toxicity. 2, 3 However, limited information is available on the effect of age and gender on xenobiotic drug metabolizing enzymes in the genetically obese obaob mouse.
CYP450 enzymes have activity towards a variety of endogenous substrates and xenobiotics. Physiological and pathological conditions such as age, gender, fasting, hepatic damage, diabetes, in¯ammation and obesity have all been demonstrated to alter CYP450 activity in humans and experimental animals. 4 ± 7 Similar studies have also examined the effects of these phenomena on Phase II metabolism. 8, 9 The spontaneously obese mouse, C57BLa6J-obaob is distinguished from its normal littermate by rapid weight gain and hyperglycemia. At 3 ± 4 months of age, body weight of obese mice is about double that of lean mice. In addition, the obaob mouse closely mimics adult-onset, insulin-resistant diabetes in obese humans, in that restricted diets will increase insulin response in these animals. 10 Barnett et al 6 assessed CYP450 activities and glutathione transferase activity (GST) in the obaob male mouse. These authors did not ®nd signi®cant differences in CYP450 activities in the male obaob mouse, but did report a marked reduction in GST and glutathione levels. The purpose of the present work was to more thoroughly examine gender-and age-dependent hepatic biotransformation activity and expression in the obaob mouse. In addition, the two age groups used in our studies were useful in determining the potential effect of the diabetic state on biotransformation activity and expression, since the diabetic condition begins to self-correct in this model after about four months, independent of a change in the obese condition. 10 
Materials and methods

Chemicals
All chemicals were purchased from Sigma Chemical Co. (St Louis, MO), unless otherwise stated.
Animals
obaob animals used in this study were obtained from breeding pairs of oba mice originally obtained from Jackson Laboratories (Bar Harbor, ME). Animals were housed in isolation cages at the College of Pharmacy Animal Facility. Animals had free access to standard laboratory chow (Ralston Purina) and tap water, and were maintained on a 12 h lighta12 h dark cycle. At 3 ± 4 months or 7 ± 8 months of age, animals were fasted for 18 h, and anesthetized with CO 2 . Blood was collected retro-orbitally for determination of glucose (Accu-Chek II monitor; Boheringer Mannheim, Indianapolis, IN) and animals were killed by cervical dislocation.
Microsome preparation
Livers from mice were homogenized with a Te¯on-coated tissue grinder using a 5:1 vaw ratio of 100 mM Tris-HCl (pH 7.2) containing 50 mM KCl. Homogenates were centrifuged at 10 000 g for 10 min at 4 C and microsomes were prepared from the remaining supernatants. 11 Microsomal protein was determined with bovine serum albumin as a standard by the method of Lowry et al.
12
CYP450 form-speci®c activities CYP450 form-speci®c activities of CYP1A1a1A2, CYP3A and CYP2B were estimated by determining the 0-dealkylation of alkoxyresoru®n substrates (ethoxy-EROD, benzoxy-BROD and pentoxy-resoru®n, PROD, respectively) by the method of Burke et al. 13 Substrate concentrations of 2.0 mM were used for each assay. CYP2E1-dependent, 4-Nitrophenol hydroxylase (PNP-OH, 4-nitrophenol concentration 100 mM) CYP3A-dependent erythromycin N-demethylase (ERY-DM, erythromycin concentration 1.0 mM) were assayed as previously described.
14 All reactions were initiated by the addition of a NADPHregenerating system (in 0.1 M potassium phosphate buffer) contained 14 mmol glucose-6-phosphate, 0.66 mmol NADP , and 3 units glucose-6-phosphate dehydrogenase.
Glutathione Transferase Activity (GST)
GST activity toward 1-Chloro-2,4,-dinitrobenzene (CDNB) was measured in the cytosolic fraction (100 K g supernatant) of samples by the method of Habig and Jakoby, 15 with minor modi®cations. Brie¯y, 10 ml of sample cytosol was added to individual wells of a microplate followed by 200 ml of 0.1 M KPO 4 (pH 6.5) containing 1.0 mM CDNB and 1.0 mM reduced glutathione. Absorbance of wells was monitored at 340 nm every 8 s for 2 min. Activity of samples was estimated by comparison to a standard curve of equine GST (Sigma Chemical Co,). Activity is expressed as equine equivalent unitsamg protein.
Detection of CYP1A1a1A2, CYP2E1 and CYP3A protein in microsomal fractions by ELISA Content of speci®c P450 forms was estimated by a direct ELISA. Brie¯y, 100 ml of microsomal protein (1.25 mgaml) was plated to microtiter plates along with 100 ml of carbonate-bicarbonate buffer (pH 9.0). Microsomes containing a known quantity of the speci®c CYP450 form (Gentest, Woburn, MA) of interest were added to the test plate for a standard curve (1000 fmol-1 fmol CYP450a100 mL). Plates were incubated overnight at 4 C and the plating solution removed the following morning. As a blocking agent, 100 ml of 50% fetal bovine serum (FBS) in PBS was added and plates were incubated for 1 h at 37 C. The blocking agent was removed and plates were washed three times (TBS-Tween, 10% FBS) and were incubated at 37
C for 1 h with primary antibody (anti-CYP1A, CYP2E1, CYP3A) Primary antibody was removed and after washing plates three times, plates were then incubated with 200 mlawell of antigoatalkaline phosphate conjugate. The secondary antibody was removed and plates were washed at least three times and 150 ml of K-Gold pre-mixed ELISA Phase I and Phase II metabolism in obaob mice AL Roe et al phosphatase substrate (ELISA Technologies, Lexington, KY) was added to each well and after 30 min, the plate was read at 405 nm. Absorbance of sample containing wells was compared to a standard curve. Values are expressed as pmol speci®c CYP450amg protein.
Northern blot analyses
Total RNA was isolated from approximately 100 mg of mouse liver tissue using Trizol# reagent (GIBCOaBRL, Long Island, NY) which is based on the method of Chomczynski and Sacchi. 16 RNA samples (20 mg) were resolved by electrophoresis on denaturing formaldehydeaagarose gels and blotted onto nylon membrane (Nytran, Schleicher and Schuell; Keene, NH). Prehybridization and hybridization conditions were carried out as previously described. 17 Signal intensity was determined autoradiographically and quantitated by scanning densitometry (Camag TLX scanner, Muttenz, Switzerland).
Probe isolation and labeling
Northern analysis cDNA probes were used. A CYP1A2 cDNA was purchased from ATCC (clone pmP3450-3', Rockville, MD; Daniel Nebert, Depositor). A CYP2E1 cDNA (pJL2a3a) was kindly provided by Dr Minor Coon, University of Michigan, Ann Arbor, MI and Dr Todd Porter, University of Kentucky, Lexington, KY. Probes were radiolabeled by random prime labeling reactions using a-32 P-dCTP and the large fragment of DNA Polymerase I (Klenow fragment, GIBCOaBRL) according to the method of Feinberg et al. 18 An oligonucleotide for 28S rRNA, labeled with g-32 P ATP and polynucleotide T4 kinase, was used to normalize loading of total RNA.
Statistical analysis
Data from in vitro experiments were evaluated by analysis of variance with post-hoc evaluation of differences by Student-Newman-Keuls test (P 0.05). The tests were performed using a SAS General Linear Models program (SAS Institute, Cary, NC) on an IBM personal computer.
Results
Obese (obaob) mice of both sexes had body weights that were nearly twice that of their lean counterparts; no differences in body weights were observed based on age or gender of the animals ( Table 1) . Young obese animals (3 ± 4 months) were hyperglycemic with blood glucose levels 2 ± 3 times higher than lean littermates; however, by 7 ± 8 months of age, blood glucose levels from obese mice were not different from lean animals ( Table 1) .
Total CYP450, CYP450-dependent, form-speci®c activities in liver microsomes and cytosolic GST activity were determined for male and female obaob mice killed at 3 ± 4 or 7 ± 8 months ( Table 2) . Total cytochrome P450, BROD or PROD activities were not affected by gender, age or phenotypic group. CYP1A-dependent EROD activity was signi®cantly decreased in old, obese males and both ages of obese females. CYP2E1-dependent, PNP-OH activity was greatly increased in obese female mice regardless of age. No differences in PNP-OH activity were observed among male mice. CYP3A-dependent ERY-DM activity was unchanged by phenotype; however, there was an age-dependent decrease in this activity in male mice. GST-CDNB activity was decreased in obese male mice, regardless of glycemic state. In contrast, no differences in GST-CDNB activity were observed in females of either phenotype or age in our study. CYP1A2, CYP2E1 and CYP3A protein levels in hepatic microsomes from male and female obaob mice were estimated by ELISA. CYP1A2 protein levels were lower in both female and male obese mice of either age group, consistent with EROD activity (Table 3) . CYP2E1 protein levels were clearly increased in obese female mice of both age groups. Differences in male mice were less evident, consistent with CYP2E1-dependent PNP-OH activity.
Since female obaob mice displayed the greatest difference in CYP1A2-and CYP2E1-form speci®c activities and protein levels, Northern analysis of CYP1A2 and CYP2E1 mRNA levels was performed (Figure 1 ). Expression levels of CYP1A2 mRNA were greater than 2-fold higher (by densitometric analysis) in lean female mice of either age group. The expression levels of CYP2E1 mRNA, in contrast to elevated CYP2E1-dependent activity and protein levels, were more than 2-fold lower in obese female mice of both age groups.
Discussion
The results of this study clearly show an age-and gender-dependent effect on the activity and expression of numerous hepatic CYP450 enzymes as well as glutathione transferase, in the obese obaob mouse. Age was an important consideration in this rodent model, because of the known changes in blood glucose and insulin concentrations over the lifetime of these animals. 9 As diabetes is known to increase the expression and activity of certain hepatic CYP450 enzymes, in particular CYP2E1, our ®nding of increased activity and protein concentration of CYP2E1 in young female obaob mice was not unexpected. However it is not clear why this increase was observed in female obaob mice. Numerous studies have examined the effect of diabetes on CYP450 activities. Rouer and Leroux 19 examined P450-dependent activities in young, obese and lean male obaob mice, dbadb mice, and mice made diabetic by streptozotocin treatment. They reported no differences in obaob mice of either phenotype, but did see larger differences in mice treated with streptozotocin. Barnett et al 8 reported on gender-dependent differences in CYP450 activities of rats made diabetic by streptozotocin; EROD, PROD and PNP-OH were all increased in the diabetic animals, with larger increases in PNP-OH observed in males. However, based on our results, the increase of CYP2E1 observed in obese female obaob mice, appears to be unrelated to diabetes, as the increased levels of CYP2E1 persist after blood glucose selfcorrects in these mice, that is, normoglycemic animals of 7 ± 8 months of age (Table 1 and  Table 2 ).
While CYP2E1 activity and protein were about 2-fold higher in obese females vs lean, Northern blot analysis demonstrated that CYP2E1 mRNA was lower in the obese animals. This contradiction between CYP2E1 activityaprotein and mRNA level, is most likely a result of protein stabilization or decreased destruction, as has also been reported by Porter, 20 to occur in livers of ethanol-treated rabbits. Barnett et Phase I and Phase II metabolism in obaob mice AL Roe et al al 7 examined CYP450 activities in male obaob mice at 16 weeks of age. These authors reported no differences between lean and obese mice for CYP1A-, CYP2B-, CYP2E1-, CYP3A-and CYP4-dependent activities. While we observed similar results for other forms in young mice, we found that CYP1A protein and EROD were signi®cantly lower in old, obese mice of both sexes, and CYP3A protein and activity were lowered in old males regardless of obesity. Raucy et al 5 reported increased levels of PNP-OH activity in rats fed an energy dense diet. While CYP2E1 protein levels were increased 2-fold in these animals, no differences were observed in immunoblots developed with CYP1A2 antibody. Furthermore CYP3A-dependent, ERY-DM was unchanged in these rats; however, the authors did not look at agerelated differences. Higher levels of CYP2E1-dependent metabolism have also been correlated to obesity in humans. Bentley reported higher rates of biotransformation of the CYP2E1 substrate, halothane, in obese individuals compared to those of normal weight.
3 O'Shea et al 21 also reported increased CYP2E1-dependent biotransformation toward chlorzoxasone in obese individuals.
Gender-dependent differences in CYP450 activities in rodents have been known for some time. In general, male rats have been observed to have higher levels of certain metabolizing enzymes; in mice this situation, if present, is reversed and results from species-and gender-dependent patterns of growth hormone secretion. 22 Perhaps the obesity-dependent increase observed in female obaob mice reported herein, are the result of differences in growth hormone secretion acting in concert with the obese state.
GST-CDNB activity was found to be greatly decreased in obese male obaob mice, regardless of age. In contrast, neither obesity nor age had any effect on GST-CDNB activity in female obaob mice. Our ®ndings are in agreement with Barnett et al 7 who also observed decreased activity of this enzyme in male mice; these authors did not examine female mice or older animals. Obesity in humans is often associated with increased Phase II activity; glucuronidation, sulfotransferases and glutathione conjugation have all been reported to be increased in obese individuals compared to normal weight subjects. 23, 24 Our report details CYP450-dependent and GST activities and content of speci®c CYP450 forms in obese and lean, male and female obaob mice. Because humans do not normally display sexual dimorphism of CYP450 activities, and obesity has been noted to increase CYP2E1-dependent metabolism, obese individuals may be at increased risk from those environmental agents that require CYP2E1-dependent metabolism for activation to toxic metabolites. Moreover, because Phase II enzymes are usually increased in obese persons, special attention is warranted in administration of therapeutic agents that may have increased or decreased ef®cacy due to altered metabolism.
